NFASC and Alzheimer disease: Recent studies have shown that CSF Nf levels might serve as a prognostic marker in multiple sclerosis [20], may assist in the differential diagnosis between frontotemporal dementia (FTD) and early onset AD [21], and may help distinguish Parkinsonian syndromes in combination with CSF tau levels [22], [23].